As drug candidates discovered via AI move into later-stage clinical trials, the technology seems to be doing as promised: ...
Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...
A global contract development and manufacturing organization focused on drug-device combination products. The company ...
In 2025, the U.S. Food and Drug Administration (FDA or the Agency) issued a surprising number of enforcement letters to ...
There is a good reason for health insurers to occasionally require prior authorization for medical treatment. If a doctor ...
Investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) saw the price of their shares crater 50% on December 31, 2025 after the company announced its receipt of a complete response letter ("CRL" ...
Quantum computers could revolutionize everything from drug discovery to business analytics—but their incredible power also ...
GlobalData on MSN
Genespire to take rare disease gene therapy to clinic in 2026
GENE202 is a single dose gene therapy for patients with rare metabolic disease, methylmalonic acidaemia.
Russia is facing a shortage of drugs which are used for the treatment of schizophrenia, psychosis, bipolar disorder, and ...
Nearly half of Massachusetts voters who signed a petition to put a marijuana legalization rollback initiative on the ballot ...
The Detroit Field Office of U.S. Customs and Border Protection (CBP) intercepted approximately 4,400 pounds of cocaine and ...
Apogee Therapeutics (APGE) leverages IL-13 pathway optimization to enable less frequent dosing, targeting a leadership shift ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results